Together With
Today is Tuesday, November 17, 2026.
The Early Bird Index today is 73.77.
New to this newsletter? Sign up here
PRESENTED BY FINANCIAL POISE
Hold My Beer: How American Rebel Turned Patriotism into a Dilution Machine
American Rebel Holdings sells beer and a whole lot of patriotism. But its SEC filings tell a very different story.
Independent investigative researcher Matthew Miller uses American Rebel as a case study of a dangerous corner of the micro-cap market.
In a nutshell:
Revenue fell from around $16 million in 2023 to roughly $9.5 million in 2025. By mid-2026, the company had accumulated a $112.4 million deficit and was down to about $96,000 in cash.
Meanwhile, American Rebel spent heavily on marketing and sponsorships, sometimes paying with stock rather than cash.
Shareholders paid the price. The company carried out seven reverse stock splits as it repeatedly issued new shares. It was ultimately delisted from Nasdaq in 2026.
American Rebel’s story is part of a pattern in the micro-cap market: companies can use public markets, convertible debt, repeated stock issuance, and reverse splits to keep themselves operating, while existing shareholders are diluted again and again.
Want more stories like this? Subscribe to the FP Weekly newsletter for free, easy-to-digest, independent analysis of the stories that matter.
Bitcoin: Too Many Culprits 🕵️
While the price of Bitcoin $BTC ( ▲ 0.87% ) stabilized on Monday, it came after a bad week. The price fell 16% in November and just hit a 4-month low.
Details: Most of the November decline occurred in the past week. It was caused by a combination of factors.
Higher inflation shifted expectations toward tighter Fed policy, making interest-paying assets more competitive and the backdrop less favorable for speculative investments such as Bitcoin.
Buying for U.S. spot Bitcoin ETFs (exchange-traded funds) declined. There were roughly $1.9 billion in net outflows across seven trading sessions through November 13.
A broader technology selloff in the stock market reduced appetite for risky assets, such as cryptocurrency.
The Binance hack also added crypto-specific security concerns to the unease.
Early Bird’s Nest Egg Gains: The pressures behind the selloff haven’t clearly disappeared. Dollar strength, institutional selling, and forced liquidations are still weighing on Bitcoin.
Final Thoughts: And it’s not just Bitcoin. Most other major crypto prices are declining in the middle of November.
Notables
Notable Earnings Today: Nvidia (Nasdaq: NVDA), Home Depot (NYSE: HD), Walt Disney (NYSE: DIS), Klarna Group (NYSE: KLAR), JD.com (Nasdaq: JD), La-Z-Boy (NYSE: LZB), Amer Sports (NYSE: AS), Viking Holdings (NYSE: VIK), Golub Capital (Nasdaq: GBDC), Tencent Music (NYSE: TME), Dolby Labs (NYSE: DLB), Energizer (NYSE: ENR), Spire (NYSE: SR), Corporacion America Airports (NYSE: CAAP), Gladstone Capital (Nasdaq: GLAD), I3 Verticals (Nasdaq: III), IRIDEX (Nasdaq: IRIX), Opera (Nasdaq: OPRA), Sociedad Quimica y Minera de Chile SA (NYSE: SQM), ZTO Express (NYSE: ZTO).
Notable IPOs Today: Torex Resources Inc. (NYSE: TXR).
Notable Equity Crowdfunding Campaigns Ending Today: N/A.
Notable Economic Events Today: ADP Employment Change Weekly (8:15 a.m. ET), Retail Sales / Core Retail Sales (8:30 a.m. ET), Export Price Index / Import Price Index (8:30 a.m. ET), Industrial Production (9:15 a.m. ET), Retail Inventories Excluding Auto (10:00 a.m. ET), Business Inventories (10:00 a.m. ET), API Weekly Crude Oil Stock (4:30 p.m. ET).
Red Cat Withdraws Outlook
The defense technology and drone manufacturer Red Cat Holdings $RCAT ( ▼ 7.11% ) plunged 26.19% in after-hours trading on Monday after posting bad financial results and withdrawing its financial outlook.
Financials: Red Cat reported a loss of 26 cents per share in the past quarter and revenue of $11.8 million. Both were lower than expected.
Final Thoughts: The stock was already down 61% in 2026.
Aytu Biopharma Gets Acquired
Aytu Biopharma $AYTU ( ▲ 2.25% ) surged 43.96% in after-hours trading on Monday after announcing good financial results and that the company is being acquired by Rosemont Pharmaceuticals.
Financials: Aytu BioPharma reported a loss of 20 cents per share in the past quarter and revenue of $14.8 million. Both were better than expected.
Final Thoughts: It’s a slight recovery for the stock, which has been down 95% since 2021.
Trends to Watch
Cyberdefense Support Program: Google to give Japan early access to frontier AI for cybersecurity (Nikkei)
From Trading Predictions to Trading Stocks: Kalshi Buys Securities Firm to Expand Into Stock Trading (Wall Street Journal)
Hopeful: Could Anthropic’s IPO Reverse the Market’s Sentiment on AI? (The Globe and Mail)
More Outages: Major banking outage linked to Chase, impacted Wells Fargo and BofA (USA Today)
Making Several Moves: Berkshire Hathaway raised its stake in Delta in the third quarter. It also trimmed a key bank holding (CNBC)
Thank you for reading!
Forward to a friend and tell them to sign up here.
Pick winning stocks: Upgrade to Early Bird Prime.
Become a smarter investor: Get Early Bird Exclusives
Connect with other investors: Join The Nest
Want more investing tips? Listen to the podcast.
Show Your Support: Buy Me a Coffee.
Questions or comments? Hit reply to reach out.
The contents of Early Bird are intended for informational and entertainment purposes only. They do not constitute trade or investment recommendations, and they are not financial or legal advice. Readers are encouraged to consult licensed professionals for personalized guidance regarding their financial or legal situations.


